Skip to main content
. 2021 Jan 8;14:125–138. doi: 10.2147/OTT.S287931

Figure 2.

Figure 2

PDIA4 is a prognostic factor for glioma patients. (A and B) Kaplan–Meier survival analysis showing high PDIA4 expression predicts poor prognosis for glioblastoma multiform (GBM) patients in both the TCGA and CGGA datasets. The upper quartile number was used in this analysis. (C and D) Kaplan–Meier survival analysis showing that high PDIA4 expression predicts poor prognosis for lower grade glioma (LGG) patients in both the TCGA and CGGA datasets. The median number was used in this analysis.